Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1637, 2008-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Benefit-Risk Assessment of Misoprostol for Cervical Ripening and Labour Induction
By Wing D.A.
Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. :
Access to resources
Recommend
Misoprostol: Lichenoid eruption (first report) following vaginal administration: case report
Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. :
Sublingual misoprostol compared with vaginal misoprostol for medical abortion
Inpharma, Vol. 1, Iss. 1592, 2007-01 ,pp. :
Lumiracoxib has no significant effect on ethinylestradiol/levonorgestrel PK or PD parameters
Reactions Weekly, Vol. 1, Iss. 1008, 2004-01 ,pp. :